Course

Diagnosing the Disease – What Sets PsA Apart from Other Rheumatic Diseases?

Upon completion of this activity, participants should be able to assess the most common clinical examination and laboratory findings in patients presenting with possible psoriatic arthritis (PsA) and identify the specific characteristics of PsA that differentiate the condition from other common rheumatic diseases.

0 out of 3 steps completed0%
0 Lessons
Start Course

Faculty

Linda Grinnell-Merrick, MS, NP-BC
Nurse Practitioner
University of Rochester Medical Center
Division of Allergy, Immunology, and Rheumatology
Rochester, NY

Target Audience

This activity has been designed to meet the educational needs of rheumatology nurses, nurse practitioners, and physician assistants. Other healthcare providers may also participate. 

Learning Objectives and Goals:
Upon completion of this activity, participants should be able to:

  • Assess the most common clinical examination and laboratory findings in patients presenting with possible psoriatic arthritis (PsA)
  • Identify the specific characteristics of PsA that differentiate the condition from other common rheumatic diseases

Accreditation Statement

The Rheumatology Nurses Society is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (Provider No. P0500). 

Rheumatology Nurses Society designates this educational activity for 0.25 contact hours. 

Disclosure Statement

According to the disclosure policy of RNS, all faculty, planning committee members, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity, and levels of evidence. 

Relationships are abbreviated as follows: E, Educational planning committee; G, Grant/research support recipient; A, Advisor/review panel member; C, Consultant; S, Stock shareholder; SB, Speaker bureau; PE, Promotional event talks; H, Honoraria; O, Other.

Disclosures are as follows:

Linda Grinnell-Merrick, MS, NP-BC, has disclosed the following relevant financial relationships specific to the subject matter of the content included in this educational activity: Janssen, AbbVie, Novartis/C, SB; Sanofi, Celgene/SB; Sandoz, Pfizer/C.

Planning Committee

Kim Cheramie, MSN, RN-BC, Lead Nurse Planner, Rheumatology Nurses Society, has disclosed that she does not have any relevant financial relationships specific to the subject matter of the content of the activity.

Scott Kober, MBA, President, MedCaseWriter, has disclosed that he does not have any relevant financial relationships specific to the subject matter of the content of the activity.

Kevin Lyons, Executive Director of the Rheumatology Nurses Society and Chief Executive Officer of Lyons Den Solutions, LLC, has disclosed that he does not have any relevant financial relationships specific to the subject matter of the content of the activity.

Off-Label Product Disclosure

This activity will not include a discussion of off-label or investigational use of products. 

Method of Participation

There are no fees to participate in the activity. Participants must review the activity information including the learning objectives and disclosure statements, as well as the content of the activity. To receive CNE contact hours for your participation, please complete the post-test (achieving a passing grade of 75% or greater), and program evaluation. Your certificate can be printed immediately. 

Supporter
This activity is supported by educational grants from Lilly and Celgene.